C

Caliway Biopharmaceuticals Co Ltd
TWSE:6919

Watchlist Manager
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
Watchlist
Price: 145.5 TWD -1.36% Market Closed
Market Cap: 225.7B TWD

Dividends

Caliway Biopharmaceuticals Co Ltd
does not pay dividends

Shareholder Yield

Current shareholder yield for Caliway Biopharmaceuticals Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Peers Comparison
Shareholder Yield

Company Total Yield Dividend Yield Buyback Yield Debt Paydown Yield

Buybacks

Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.

This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.

Unlock Buyback Yield

Peers Comparison
Buybacks

Company Buyback Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Debt Paydown

Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.

This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.

Unlock Debt Paydown Yield

Peers Comparison
Debt Paydown

Company Debt Paydown Yield Average Yield (3Y) Average Yield (5Y) Average Yield (10Y)

Price Appreciation

Price
Caliway Biopharmaceuticals Co Ltd

1M 1M
-9%
6M 6M
+20%
1Y 1Y
+132%
3Y 3Y
+1 759%
5Y 5Y
+2 147%
10Y 10Y
+2 147%
Annual Price Range
145.5
52w Low
57
52w High
257.5
Price Metrics
Average Annual Return 141.88%
Standard Deviation of Annual Returns 132.31%
Max Drawdown -100%
Shares Statistics
Market Capitalization 225.7B TWD
Shares Outstanding 1 550 900 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Stock Splits

Caliway Biopharmaceuticals Co Ltd's latest stock split occurred on Jul 14, 2025

The company executed a 10-for-1 stock split, meaning that for every share held, investors received 10 new shares.

Before the split, Caliway Biopharmaceuticals Co Ltd traded at 121.5 per share. Afterward, the share price was about 121.5.

The adjusted shares began trading on Jul 14, 2025. This was the only stock split in Caliway Biopharmaceuticals Co Ltd's history.

Pre-Split Price
121.5 121.5
Post-Split Price
121.5
Before
After